CIT GROUP INC. Common Stock Underwriting AgreementUnderwriting Agreement • April 25th, 2008 • Cit Group Inc • Finance lessors • New York
Contract Type FiledApril 25th, 2008 Company Industry JurisdictionCIT Group Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 91,000,000 shares (the “Initial Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company proposes to sell to the Underwriters up to an additional 13,650,000 shares of the Company’s Common Stock (the “Option Shares”) with respect to the grant by the Company to the Underwriters of the option described in Section 2(b) hereof, solely to cover over-allotments. The Initial Shares to be purchased by the Underwriters and all or any part of the Option Shares are hereinafter called, collectively, the “Shares.”
CIT GROUP INC. 10,000,000 Shares of 8.75% Non-Cumulative Perpetual Convertible Preferred Stock, Series C Underwriting AgreementUnderwriting Agreement • April 25th, 2008 • Cit Group Inc • Finance lessors • New York
Contract Type FiledApril 25th, 2008 Company Industry JurisdictionCIT Group Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 10,000,000 shares (the “Initial Securities”) of the Company’s 8.75% Non-Cumulative Perpetual Convertible Preferred Stock, Series C, par value $0.01 and liquidation preference $50 per share (the “Preferred Stock”), convertible into shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company. In addition, the Company proposes to sell to the Underwriters up to an additional 1,500,000 shares of the Company’s 8.75% Non-Cumulative Perpetual Convertible Preferred Stock, Series C (the “Option Securities”) with respect to the grant by the Company to the Underwriters of the option described in Section 2(b) hereof, solely to cover over-allotments. The Initial Securities to be purchased by the Underwriters and all or any part of